Literature DB >> 19880957

Trait anger, hostility, serum homocysteine, and recurrent cardiac events after percutaneous coronary interventions.

Eun Kyeung Song1, Youn-Jung Son, Terry A Lennie.   

Abstract

BACKGROUND: Trait anger, hostility, and serum level of homocysteine are associated with recurrent cardiac events after percutaneous coronary interventions. However, whether trait anger or hostility influences the association between serum level of homocysteine and recurrent cardiac events is unknown.
OBJECTIVES: To examine the relationships among trait anger, hostility, serum level of homocysteine, and recurrent cardiac events after percutaneous coronary interventions.
METHODS: This prospective study included 135 consecutive patients (68% male, mean age 61 [SD, 10] years) undergoing percutaneous coronary interventions during an index hospitalization. Trait anger and hostility were measured with the Spielberger Trait Anger Scale and the Cynical Hostility Scale, respectively. Blood samples were obtained to measure serum levels of total cholesterol, triglycerides, high- and low-density lipoprotein cholesterol, and homocysteine. Recurrent cardiac events (emergency department visits and rehospitalization) were noted for 6 months after discharge and confirmed by review of hospital records. Hierarchical Cox hazard regression was used for statistical analysis.
RESULTS: Trait anger (hazard ratio = 1.11, 95% confidence interval = 1.03-1.20) and homocysteine level (hazard ratio = 1.10, 95% confidence interval = 1.01-1.21) were independent predictors of recurrent cardiac events after other risk factors were controlled for. Patients with high trait anger (score > or = 24) and high serum level of homocysteine (> or = 11.3 mumol/L) had the shortest time to recurrent cardiac events (P = .01).
CONCLUSION: Trait anger had a combined effect on the link between serum level of homocysteine and recurrent cardiac events. Interventions to reduce trait anger may improve health outcomes by influencing both trait anger and homocysteine level.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19880957      PMCID: PMC3494734          DOI: 10.4037/ajcc2009974

Source DB:  PubMed          Journal:  Am J Crit Care        ISSN: 1062-3264            Impact factor:   2.228


  51 in total

1.  Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid.

Authors:  M Ward; H McNulty; J McPartlin; J J Strain; D G Weir; J M Scott
Journal:  QJM       Date:  1997-08

Review 2.  Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis.

Authors:  Linda L Humphrey; Rongwei Fu; Kevin Rogers; Michele Freeman; Mark Helfand
Journal:  Mayo Clin Proc       Date:  2008-11       Impact factor: 7.616

3.  Effects of homocysteine on smooth muscle cell proliferation in both cell culture and artery perfusion culture models.

Authors:  C Chen; M E Halkos; S M Surowiec; B S Conklin; P H Lin; A B Lumsden
Journal:  J Surg Res       Date:  2000-01       Impact factor: 2.192

Review 4.  Total homocysteine and cardiovascular disease.

Authors:  O Nygård; S E Vollset; H Refsum; L Brattström; P M Ueland
Journal:  J Intern Med       Date:  1999-11       Impact factor: 8.989

Review 5.  Homocysteine and atherosclerosis.

Authors:  G T Gerhard; P B Duell
Journal:  Curr Opin Lipidol       Date:  1999-10       Impact factor: 4.776

6.  Homocysteine accelerates endothelial cell senescence.

Authors:  D Xu; R Neville; T Finkel
Journal:  FEBS Lett       Date:  2000-03-17       Impact factor: 4.124

7.  Serum total homocysteine concentrations and risk of mortality from stroke and coronary heart disease in Japanese: The JACC study.

Authors:  Renzhe Cui; Yuri Moriyama; Kazuko A Koike; Chigusa Date; Shogo Kikuchi; Akiko Tamakoshi; Hiroyasu Iso
Journal:  Atherosclerosis       Date:  2008-03-04       Impact factor: 5.162

Review 8.  Emotional triggering of cardiac events.

Authors:  Andrew Steptoe; Lena Brydon
Journal:  Neurosci Biobehav Rev       Date:  2008-05-03       Impact factor: 8.989

9.  The neural substrates of affective face recognition in patients with Hwa-Byung and healthy individuals in Korea.

Authors:  Byeong-Taek Lee; Jong-Woo Paik; Rhee-Hun Kang; Sun-Yong Chung; Ho-In Kwon; Hyun-Soo Khang; In Kyoon Lyoo; Jeong-Ho Chae; Jung-Hye Kwon; Jong-Woo Kim; Min-Soo Lee; Byung-Joo Ham
Journal:  World J Biol Psychiatry       Date:  2009       Impact factor: 4.132

10.  Randomized, double-blind, multicenter study of the polymer-based 17-beta estradiol-eluting stent for treatment of native coronary artery lesions: six-month results of the ETHOS I trial.

Authors:  Alexandre Abizaid; Aurea J Chaves; Martin B Leon; Karl Hauptmann; Roxana Mehran; Alexandra J Lansky; William Baumbach; Hari Shankar; Ralf Muller; Fausto Feres; Amanda G M R Sousa; J Eduardo Sousa; Eberhard Grube
Journal:  Catheter Cardiovasc Interv       Date:  2007-11-01       Impact factor: 2.692

View more
  1 in total

1.  Micronutrient Deficiency Independently Predicts Time to Event in Patients With Heart Failure.

Authors:  Terry A Lennie; Christina Andreae; Mary Kay Rayens; Eun Kyeung Song; Sandra B Dunbar; Susan J Pressler; Seongkum Heo; JinShil Kim; Debra K Moser
Journal:  J Am Heart Assoc       Date:  2018-09-04       Impact factor: 5.501

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.